Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
Rodríguez-Nóvoa
Sonia
S
Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
Labarga
Pablo
P
D'avolio
Antonio
A
Barreiro
Pablo
P
Albalate
Marta
M
Vispo
Eugenia
E
Solera
Carmen
C
Siccardi
Marco
M
Bonora
Stefano
S
Di Perri
Giovanni
G
Soriano
Vincent
V
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007677:Kidney Function Tests; D007684:Kidney Tubules / Q000187:drug effects / Q000293:injuries; D063065:Organophosphonates / Q000009:adverse effects* / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000097:blood; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine